Search research articles
Contact Us
Filters
Showing results (111-120 of 198) with videos related to
Page
of 20
Sort By:
Biomedicines
|
April 23, 2022
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
Marjorie C Gondré-Lewis, Igor Elman, Tanya Alim, et al.
Biomedical Journal of Scientific & Technical Research
|
October 30, 2018
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis
Kenneth Blum, Edward J Modestino, Jennifer Neary, et al.
Acta Scientific Neurology
|
August 9, 2024
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss
Edward J Modestino, Abdalla Bowirrat, Kai-Uwe Lewandrowski, et al.
Psychology Research and Behavior Management
|
February 6, 2025
Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case Series
Keerthy Sunder, Milan T Makale, Miles Makale, et al.
Journal of Addiction Psychiatry
|
August 10, 2023
Psychostimulants for Children: Are We Over or Under Dosing?
Kenneth Blum, Catherine Dennen, Paul R Carney, et al.
Acta Scientific Neurology
|
March 8, 2021
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
Kenneth Blum, Ali Raza, Tiffany Schultz, et al.
International Journal of Environmental Research and Public Health
|
January 11, 2022
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors
Ashim Gupta, Abdalla Bowirrat, Luis Llanos Gomez, et al.
Current Psychopharmacology
|
September 1, 2021
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) <i>via</i> Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Kenneth Blum, Edward J Modestino, David Baron, et al.
Kidney360
|
January 14, 2025
Establishing Meaningful Patient-Centered Outcomes with Relevance for Patients with Polycystic Kidney Disease: Patient, Caregiver, and Researcher Priorities for Research in Polycystic Kidney Disease
Reem A Mustafa, Hassan Kawtharany, Mohamad A Kalot, et al.
International Journal of Environmental Research and Public Health
|
September 28, 2021
Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?
Kenneth Blum, Mark S Gold, Luis Llanos-Gomez, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 198) with videos related to
Sort By:
Page
of 20
Biomedicines
|
April 23, 2022
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
Marjorie C Gondré-Lewis, Igor Elman, Tanya Alim, et al.
Biomedical Journal of Scientific & Technical Research
|
October 30, 2018
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis
Kenneth Blum, Edward J Modestino, Jennifer Neary, et al.
Acta Scientific Neurology
|
August 9, 2024
Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss
Edward J Modestino, Abdalla Bowirrat, Kai-Uwe Lewandrowski, et al.
Psychology Research and Behavior Management
|
February 6, 2025
Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case Series
Keerthy Sunder, Milan T Makale, Miles Makale, et al.
Journal of Addiction Psychiatry
|
August 10, 2023
Psychostimulants for Children: Are We Over or Under Dosing?
Kenneth Blum, Catherine Dennen, Paul R Carney, et al.
Acta Scientific Neurology
|
March 8, 2021
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
Kenneth Blum, Ali Raza, Tiffany Schultz, et al.
International Journal of Environmental Research and Public Health
|
January 11, 2022
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors
Ashim Gupta, Abdalla Bowirrat, Luis Llanos Gomez, et al.
Current Psychopharmacology
|
September 1, 2021
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) <i>via</i> Activation of Neuro-immunological Function in the Face of a Viral Pandemic
Kenneth Blum, Edward J Modestino, David Baron, et al.
Kidney360
|
January 14, 2025
Establishing Meaningful Patient-Centered Outcomes with Relevance for Patients with Polycystic Kidney Disease: Patient, Caregiver, and Researcher Priorities for Research in Polycystic Kidney Disease
Reem A Mustafa, Hassan Kawtharany, Mohamad A Kalot, et al.
International Journal of Environmental Research and Public Health
|
September 28, 2021
Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?
Kenneth Blum, Mark S Gold, Luis Llanos-Gomez, et al.
Page
of 20